Time to Treatment and Three-Year Mortality After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) Substudy

American Journal of Cardiology

Volumn 105, Issue 11, 2010, Pages 1528-1534

  Maeng, Michael ^a   Nielsen, Peter Haubjerg ^a   Busk, Martin ^a   Mortensen, Leif Spange ^b   Kristensen, Steen Dalby ^a   Toftegaard Nielsen, Torsten ^a   Andersen, Henning Rud ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNI C   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; NITRATE; TICLOPIDINE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL TIME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONFIDENCE INTERVALS; DENMARK; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STENTS; STROKE VOLUME; SURVIVAL ANALYSIS; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952426080     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.005     Document Type: Article

References (31)

1. Antoniucci D., Valenti R., Migliorini A., Moschi G., Trapani M., Buonamici P., Cerisano G., Bolognese L., and Santoro G.M. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 89 (2002) 1248-1252
2. Berger P.B., Ellis S.G., Holmes Jr. D.R., Granger C.B., Criger D.A., Betriu A., Topol E.J., and Califf R.M. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO-IIb) trial. Circulation 100 (1999) 14-20
3. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 27 (2006) 779-788
4. Brodie B.R., Stuckey T.D., Wall T.C., Kissling G., Hansen C.J., Muncy D.B., Weintraub R.A., and Kelly T.A. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 32 (1998) 1312-1319
5. Brodie B.R., and Kissling G. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction. Circulation 102 (2000) E29-E30
6. Brodie B.R., Stone G.W., Morice M.C., Cox D.A., Garcia E., Mattos L.A., Boura J., O'Neill W.W., Stuckey T.D., Milks S., Lansky A.J., and Grines C.L. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol 88 (2001) 1085-1090
7. Brodie B.R., Stuckey T.D., Hansen C.J., VerSteeg D., Muncy D., Pulsipher M., and Gupta N. Effect of treatment delay on outcomes in patients with acute myocardial infarction transferred from community hospitals for primary percutaneous coronary intervention. Am J Cardiol 89 (2002) 1243-1247
8. Brodie B.R., Stuckey T.D., Muncy D.B., Hansen C.J., Wall T.C., Pulsipher M., and Gupta N. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J 145 (2003) 708-715
9. Brodie B.R., Stone G.W., Cox D.A., Stuckey T.D., Turco M., Tcheng J.E., Berger P., Mehran R., McLaughlin M., Costantini C., Lansky A.J., and Grines C.L. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. Am Heart J 151 (2006) 1231-1238
10. Brodie B.R., Hansen C., Stuckey T.D., Richter S., Versteeg D.S., Gupta N., Downey W.E., and Pulsipher M. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol 47 (2006) 289-295
11. Brodie B.R., Webb J., Cox D.A., Qureshi M., Kalynych A., Turco M., Schultheiss H.P., Dulas D., Rutherford B., Antoniucci D., Stuckey T., Krucoff M., Gibbons R., Lansky A., Na Y., Mehran R., and Stone G.W. Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). Am J Cardiol 99 (2007) 1680-1686
12. Cannon C.P., Gibson C.M., Lambrew C.T., Shoultz D.A., Levy D., French W.J., Gore J.M., Weaver W.D., Rogers W.J., and Tiefenbrunn A.J. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
13. Chareonthaitawee P., Gibbons R.J., Roberts R.S., Christian T.F., Burns R., and Yusuf S. The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation). Heart 84 (2000) 142-148
14. De Luca G., Suryapranata H., Zijlstra F., van't Hof A.W., Hoorntje J.C., Gosselink A.T., Dambrink J.H., and de Boer M.J. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42 (2003) 991-997
15. De Luca G., Suryapranata H., Ottervanger J.P., and Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004) 1223-1225
16. McNamara R.L., Wang Y., Herrin J., Curtis J.P., Bradley E.H., Magid D.J., Peterson E.D., Blaney M., Frederick P.D., and Krumholz H.M. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 47 (2006) 2180-2186
17. Milavetz J.J., Giebel D.W., Christian T.F., Schwartz R.S., Holmes Jr. D.R., and Gibbons R.J. Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol 31 (1998) 1246-1251
18. O'Keefe Jr. J.H., Grines C.L., DeWood M.A., Bateman T.M., Christian T.F., and Gibbons R.J. Factors influencing myocardial salvage with primary angioplasty. J Nucl Cardiol 2 (1995) 35-41
19. Schomig A., Ndrepepa G., Mehilli J., Schwaiger M., Schuhlen H., Nekolla S., Pache J., Martinoff S., Bollwein H., and Kastrati A. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 108 (2003) 1084-1088
20. Stone G.W., Dixon S.R., Grines C.L., Cox D.A., Webb J.G., Brodie B.R., Griffin J.J., Martin J.L., Fahy M., Mehran R., Miller T.D., Gibbons R.J., and O'Neill W.W. Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol 100 (2007) 1370-1375
21. Zijlstra F., Hoorntje J.C., de Boer M.J., Reiffers S., Miedema K., Ottervanger J.P., van't Hof A.W., and Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341 (1999) 1413-1419
22. Andersen H.R., Nielsen T.T., Rasmussen K., Thuesen L., Kelbaek H., Thayssen P., Abildgaard U., Pedersen F., Madsen J.K., Grande P., Villadsen A.B., Krusell L.R., Haghfelt T., Lomholt P., Husted S.E., Vigholt E., Kjaergard H.K., and Mortensen L.S. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349 (2003) 733-742
23. Andersen H.R., Nielsen T.T., Vesterlund T., Grande P., Abildgaard U., Thayssen P., Pedersen F., and Mortensen L.S. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J 146 (2003) 234-241
24. Busk M., Maeng M., Rasmussen K., Kelbaek H., Thayssen P., Abildgaard U., Vigholt E., Mortensen L.S., Thuesen L., Kristensen S.D., Nielsen T.T., and Andersen H.R. The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. Eur Heart J 29 (2008) 1259-1266
25. Madsen M.M., Busk M., Sondergaard H.M., Bottcher M., Mortensen L.S., Andersen H.R., and Nielsen T.T. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis (a DANAMI-2 substudy)?. Am J Cardiol 96 (2005) 1469-1475
26. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: should the paradigm be expanded?. Circulation 79 (1989) 441-444
27. Terkelsen C.J., Norgaard B.L., Lassen J.F., Poulsen S.H., Gerdes J.C., Sloth E., Gotzsche L.B., Romer F.K., Thuesen L., Nielsen T.T., and Andersen H.R. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in acute myocardial infarction study (the MONAMI study). Eur Heart J 27 (2006) 267-275
28. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasyamani L.K., Hochman J.S., Krumholz H.M., Lamas G.A., Mullany C.J., Pearle D.L., Sloan M.A., Smith Jr. S.C., Anbe D.T., Kushner F.G., Ornato J.P., Pearle D.L., Sloan M.A., Jacobs A.K., Adams C.D., Anderson J.L., Buller C.E., Creager M.A., Ettinger S.M., Halperin J.L., Hunt S.A., Lytle B.W., Nishimura R., Page R.L., Riegel B., Tarkington L.G., and Yancy C.W. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 51 (2008) 210-247
29. Nallamothu B.K., Bates E.R., Herrin J., Wang Y., Bradley E.H., and Krumholz H.M. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 111 (2005) 761-767
30. Nallamothu B.K., Bates E.R., Wang Y., Bradley E.H., and Krumholz H.M. Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation 113 (2006) 1189-1195
31. Nielsen P.H., Maeng M., Busk M., Mortensen L.S., Kristensen S.D., Nielsen T.T., Andersen H.R., and DANAMI-2 Investigators. Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial. Circulation 121 (2010) 1484-1491